Clinical trial
Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction…
NCT00311051 · Research Center Borstel, Other · Withdrawn
Key facts
| NCT number | NCT00311051 |
|---|---|
| Title | Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite |
| Official title | A Randomized Double-blind and Placebo-controlled Study to the Influence of Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Patients With Mild to Moderate Atopic Asthma (House Dust Mite) |
| Lead sponsor | Research Center Borstel, Other |
| Status | Withdrawn |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | ramatroban, montelukast |
| Enrollment | 0 |
| Start date | Apr 1, 2005 |
| Completion | Apr 1, 2007 |
| First posted | Apr 5, 2006 |
| Last update posted | Apr 16, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: